BRPI1009457A2 - domínio angiogênico sparc e métodos de uso - Google Patents
domínio angiogênico sparc e métodos de usoInfo
- Publication number
- BRPI1009457A2 BRPI1009457A2 BRPI1009457A BRPI1009457A BRPI1009457A2 BR PI1009457 A2 BRPI1009457 A2 BR PI1009457A2 BR PI1009457 A BRPI1009457 A BR PI1009457A BR PI1009457 A BRPI1009457 A BR PI1009457A BR PI1009457 A2 BRPI1009457 A2 BR PI1009457A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- angiogenic domain
- sparc angiogenic
- sparc
- domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15932209P | 2009-03-11 | 2009-03-11 | |
PCT/US2010/027041 WO2010105097A2 (en) | 2009-03-11 | 2010-03-11 | Sparc angiogenic domain and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1009457A2 true BRPI1009457A2 (pt) | 2016-03-01 |
Family
ID=42729116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1009457A BRPI1009457A2 (pt) | 2009-03-11 | 2010-03-11 | domínio angiogênico sparc e métodos de uso |
Country Status (13)
Country | Link |
---|---|
US (2) | US20120087910A1 (pt) |
EP (1) | EP2405932A4 (pt) |
JP (1) | JP2012520081A (pt) |
KR (2) | KR20130043242A (pt) |
CN (2) | CN102482334A (pt) |
AU (1) | AU2010224031B2 (pt) |
BR (1) | BRPI1009457A2 (pt) |
CA (1) | CA2755109A1 (pt) |
IL (2) | IL215089A0 (pt) |
MX (1) | MX2011009478A (pt) |
NZ (1) | NZ595528A (pt) |
WO (1) | WO2010105097A2 (pt) |
ZA (1) | ZA201107415B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2012010429A (es) * | 2010-03-11 | 2013-01-29 | Abraxis Bioscience Llc | Dominio angiogenico sparc y metodos de uso. |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000677A1 (en) * | 2000-06-07 | 2002-01-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2006112930A2 (en) * | 2005-02-18 | 2006-10-26 | Abraxis Bioscience, Inc. | Q3 sparc deletion mutant and uses thereof |
WO2008000079A1 (en) * | 2006-06-26 | 2008-01-03 | The University Of British Columbia | Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
US20080255035A1 (en) * | 2007-04-13 | 2008-10-16 | Abraxis Bioscience, Inc. | Sparc and methods of use thereof |
-
2010
- 2010-03-11 NZ NZ595528A patent/NZ595528A/xx not_active IP Right Cessation
- 2010-03-11 CN CN201080018313XA patent/CN102482334A/zh active Pending
- 2010-03-11 EP EP10751447A patent/EP2405932A4/en not_active Withdrawn
- 2010-03-11 KR KR1020137008481A patent/KR20130043242A/ko not_active Application Discontinuation
- 2010-03-11 CN CN201410016511.2A patent/CN103724417A/zh active Pending
- 2010-03-11 KR KR1020117023819A patent/KR20110139256A/ko not_active Application Discontinuation
- 2010-03-11 CA CA2755109A patent/CA2755109A1/en not_active Abandoned
- 2010-03-11 MX MX2011009478A patent/MX2011009478A/es not_active Application Discontinuation
- 2010-03-11 WO PCT/US2010/027041 patent/WO2010105097A2/en active Application Filing
- 2010-03-11 BR BRPI1009457A patent/BRPI1009457A2/pt not_active IP Right Cessation
- 2010-03-11 JP JP2011554211A patent/JP2012520081A/ja active Pending
- 2010-03-11 US US13/256,135 patent/US20120087910A1/en not_active Abandoned
- 2010-03-11 AU AU2010224031A patent/AU2010224031B2/en not_active Ceased
-
2011
- 2011-09-11 IL IL215089A patent/IL215089A0/en unknown
- 2011-10-10 ZA ZA2011/07415A patent/ZA201107415B/en unknown
-
2013
- 2013-10-08 IL IL228795A patent/IL228795A0/en unknown
- 2013-11-12 US US14/078,119 patent/US20140094416A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2010105097A2 (en) | 2010-09-16 |
WO2010105097A8 (en) | 2011-05-26 |
JP2012520081A (ja) | 2012-09-06 |
CN102482334A (zh) | 2012-05-30 |
KR20110139256A (ko) | 2011-12-28 |
US20120087910A1 (en) | 2012-04-12 |
AU2010224031A2 (en) | 2011-10-20 |
EP2405932A4 (en) | 2012-08-22 |
NZ595528A (en) | 2013-10-25 |
AU2010224031A1 (en) | 2011-10-06 |
US20140094416A1 (en) | 2014-04-03 |
IL215089A0 (en) | 2011-11-30 |
CN103724417A (zh) | 2014-04-16 |
ZA201107415B (en) | 2012-06-27 |
KR20130043242A (ko) | 2013-04-29 |
IL228795A0 (en) | 2013-12-31 |
WO2010105097A3 (en) | 2010-11-04 |
AU2010224031B2 (en) | 2013-05-02 |
EP2405932A2 (en) | 2012-01-18 |
MX2011009478A (es) | 2011-11-18 |
CA2755109A1 (en) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1014544A2 (pt) | anticorpors anti-il-17f e metodos de uso dos mesmos | |
SMT201600278B (it) | Inibitori della benzossazolo chinasi e metodi d'uso | |
BRPI0916769A2 (pt) | derivados de benzilbenzeno deuterados e métodos de uso | |
BRPI1012333A2 (pt) | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso | |
BR112012018329A2 (pt) | agentes de coloração e métodos de uso destes | |
BRPI0916269A2 (pt) | dispositivo de modificação de tecido e seu método de uso | |
BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
BRPI0922708A2 (pt) | peptídeos mini-hepcidina e métodos de uso do mesmo | |
BR112012004375A2 (pt) | toalha de praia e método de toalha de praia | |
BRPI1012676A2 (pt) | anticorpos anti-fcrh5 e imunoconjugados e métodos de uso | |
BRPI1012560A2 (pt) | anticorpos anti-fcrh5 e imunoconjugados e métodos de uso | |
BRPI1005292A2 (pt) | composição de decapagem e uso da composição | |
BRPI1011384A2 (pt) | pro-proteinas e seus metodos de uso | |
BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
BRPI0909077A2 (pt) | Artigos multicamadas e métodos de preparo e uso dos mesmos | |
BRPI1007175A2 (pt) | Polipeptídeos hidroxifenilpriruvato dioxigenase mutantes e métodos de uso | |
BRPI1011437A2 (pt) | composicao para limpeza de tinta e metodos de uso | |
BRPI0906435A2 (pt) | anticorpos anti-cd79b e imunoconjugados e métodos de uso | |
BRPI0917535A2 (pt) | uso de insulina de ação ultra rápida | |
DOP2010000260A (es) | Derivado heterociclico fusionado y su uso | |
BRPI1009847A2 (pt) | conectores médicos e métodos de uso | |
BR112013014321A2 (pt) | moduladores inovadores e métodos de uso | |
BRPI1007494A2 (pt) | composto e uso do mesmo | |
BRPI0909954A2 (pt) | "diazacarbazóis e métodos de uso" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |